Henry H. Armstrong Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $582K | Sell |
8,433
-591
| -7% | -$40.8K | 0.05% | 42 |
|
|
2025
Q1 | $627K | Sell |
9,024
-500
| -5% | -$34.7K | 0.06% | 40 |
|
|
2024
Q4 | $819K | Hold |
9,524
| – | – | 0.08% | 38 |
|
|
2024
Q3 | $1.13M | Sell |
9,524
-800
| -8% | -$95.3K | 0.11% | 34 |
|
|
2024
Q2 | $1.47M | Hold |
10,324
| – | – | 0.15% | 30 |
|
|
2024
Q1 | $1.33M | Hold |
10,324
| – | – | 0.13% | 33 |
|
|
2023
Q4 | $1.07M | Hold |
10,324
| – | – | 0.11% | 32 |
|
|
2023
Q3 | $939K | Hold |
10,324
| – | – | 0.11% | 33 |
|
|
2023
Q2 | $835K | Sell |
10,324
-500
| -5% | -$40.5K | 0.09% | 35 |
|
|
2023
Q1 | $861K | Sell |
10,824
-6,586
| -38% | -$524K | 0.1% | 35 |
|
|
2022
Q4 | $1.18M | Hold |
17,410
| – | – | 0.15% | 34 |
|
|
2022
Q3 | $867K | Buy |
+17,410
| New | +$867K | 0.12% | 35 |
|